Tilarginine
Term · Oncology and biomedicine · MLC-T-ONC-017166
A pan-nitric oxide synthase (NOS) inhibitor, with potential immunomodulating and antineoplastic activities. Upon administration, tilarginine binds to and inhibits NOS, a free radical signaling molecule that promotes angiogenesis, metastasis, and immunosuppression in the tumor microenvironment (TME). Reduction in NOS activity may abrogate the immunosuppressive TME, enhance tumor antigen-specific immune response and inhibit tumor cell proliferation.
| Identifier | MLC-T-ONC-017166 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | NMA |
| Synonyms | N5-(methylamidino)-L-ornithine; N-methylarginine; omega-N-monomethylarginine; targinine; NG-monomethyl-L-arginine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017166",
"term": "Tilarginine",
"field": "Oncology and biomedicine",
"definition": "A pan-nitric oxide synthase (NOS) inhibitor, with potential immunomodulating and antineoplastic activities. Upon administration, tilarginine binds to and inhibits NOS, a free radical signaling molecule that promotes angiogenesis, metastasis, and immunosuppression in the tumor microenvironment (TME). Reduction in NOS activity may abrogate the immunosuppressive TME, enhance tumor antigen-specific immune response and inhibit tumor cell proliferation.",
"abbreviation": "NMA",
"synonyms": [
"N5-(methylamidino)-L-ornithine",
"N-methylarginine",
"omega-N-monomethylarginine",
"targinine",
"NG-monomethyl-L-arginine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tilarginine/"
}
Record 16,363 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.